LOL......It's a freakin' camera for crying out loud, not a cure for all diseases. Who will be the last one holding the bag? No, I'm not short GRPO, I don't short freight trains......but trust me, this will not go parabolic much longer without a $5-$7 break at least.
Unbelievable....I was short ATHL up to Friday morning, and covered when it rose above a small prior resistance. It still wasn't in an uptrend as of Friday, but I didn't like the way it came back......Thank God!
Again, I'm not saying to sell GWPH if you believe the story, but I follow charts....If GWPH should break below $82, it could head right for around $70.....And no, I'm not short and wouldn't short a biotech anyway.
If "creepy" stories are defined as those where insiders are buying huge amounts of stock, and the chart has just broken major resistance, trending higher with high volume, then I'm all for creepy.
And did I mention INSY is very profitable?
You may also want to make note of the fact that GWPH's chart broke down with a quadruple bottom breakdown last week (on Thurs.).
Based on trading from the past few sessions, it's possible INSY could make a big move up this coming week (like we saw Friday with the cancer drug stock AGIO).
This article is very positive and very timely.....thanks for the great find!.....I can't understand why it's not linked to Yahoo finance like most Motley Fool articles.
What I find amazing Pandora is that this administration feels the need to focus on and generate public support. This is an executive action, and if they have support and help from our allies, that's what matters, not whether or not Joe the plumber buys into this effort.
they may be getting beat to market by a cannabis application competitor, INSY. INSY received another orphan drug designation today for a medical cannabis application, and this one is very important. In addition, INSY already has a profitable drug portfolio, and is a profitable drug company with insider buying. I'm not saying to sell GWPH, but you may want to consider jumping in INSY.
2. Well documented recent insider buying
3. Cannabis applications receiving orphan drug exclusivity
4. On a technical basis, the stock broke out today and took out resistance.....There's not much stopping INSY from making new highs in the near term.
GWPH may get all the attention for medical cannabis applications, but the truth is INSY may be ahead of them in their effort.
1. This is a profitable company, that reported stellar results their last report
First of all their flagship drugs, although very promising, are in Phase I trials. The November presentation is for a Phase I trial progress. Cramer gave this company a mention on his show last week, and the stock took off from there. Now it's clearly overbought, and that's before the move here in pre-market.
No, I'm not short AGIO, that's insane....but I used to be long, and would consider going long again, when it sells off back into the trading channel it has been in for months. Unless the market has knowledge of Celgene taking a bigger stake, or a fast track designation by the FDA we're not aware of, look for AGIO to gradually sell off....Stocks look 6 months ahead.....not 3 years.
Read my post below on the "why is it jumping" thread. This is no mystery to me, although now with the Dow down 250 points and INSY still climbing, there may be something even bigger on the horizon as you suggest. Don't sell....we're going a lot higher.
It's nice to offer new product launches, and even better to sell those products with global demand. But it's the old story....if you can't do what you say you're going to do, in this case have the infrastructure in place to prevent these missteps, it's time for the board of directors to consider other options for this company. You would think with all this operational prep time this would have been prevented.....
1. Technical move, following up the strong recovery from last week on the weekly chart.
2. This is a very undervalued, profitable company, with strong sales of flagship drugs.
3. Potentially a future leader in cannabis related therapy applications
4. Recent insider buying indicates a strong commitment by management to the stock performance.
Need any more reasons?
You're correct. Today is a buying opportunity or great entry point for EMES.....CRR is getting pummeled, but SLCA and EMES and HCLP should benefit.
No sell off is meaningless....The momentum players bid it up, then they take their profits....that's how it works.
Julian Robertson, founder of Tiger global was on CNBC this morning, saying there were bubbles in the market. He ought to know, his firm apparently bought millions of shares of BITA at the top.
Alibaba has been in business since 1999, Bitauto since 2000. There's been no strategic alliance formed at all for 14 years, why would that change now? Just because they're both public now should not be a catalyst for an alliance. My answer is there's just no synergies at all between the two companies, other than both being Chinese internet companies.